Zadaxin thymosin alpha 1 is the synthetic peptide thymalfasin. Learn its approved uses, dosing, side effects, and US legal status in this plain-English guide.
Zadaxin is the brand name for thymosin alpha 1 (thymalfasin), a synthetic 28-amino-acid peptide modeled on a hormone produced by the thymus gland. It is a prescription medicine in a few countries, including Italy and China, where it is used for chronic hepatitis B and as a vaccine adjuvant. It is not FDA-approved for any human use in the United States.
What Is Zadaxin (Thymosin Alpha 1)?
Thymosin alpha 1 is a thymic peptide, meaning it is studied for the way it influences how immune cells mature and respond to infection. Researchers have tested it in chronic viral hepatitis, in sepsis, and as an add-on to cancer treatment and vaccines.
People who search what is thymosin alpha 1 are usually trying to answer one basic question: is this a drug, a supplement, or a research chemical? The answer depends on where you are. In a pharmacy in Rome or Shanghai, it is a regulated injectable medicine. In the US, it is generally sold as a research chemical labeled "not for human consumption."
Why Zadaxin Is the Best-Known Thymosin Alpha 1 Brand Name
Zadaxin is a trademarked product from SciClone Pharmaceuticals, and it is the version used in most published clinical trials. When a study describes a thymosin alpha 1 brand name product, Zadaxin is usually the one being referenced.
- Zadaxin (thymalfasin): 1.6 mg lyophilized powder reconstituted for subcutaneous injection, typically given twice weekly.
- Regional trade names: the same peptide is sold under local brand names in parts of Europe and Asia, and as generic thymalfasin in some markets.
- Research listings: US suppliers usually sell it as plain "thymosin alpha 1" powder with no brand attached.
Zadaxin is a brand name, not a separate drug. The active ingredient in every Zadaxin vial is thymosin alpha 1.
It also helps to know how it differs from lookalike products. The comparison thymalin vs thymosin alpha 1 comes up often because both are thymus-derived peptides. Thymalin is a bovine thymus extract containing many short peptide fragments, while thymosin alpha 1 is a single synthetic 28-amino-acid chain. A defined single molecule is easier to standardize and study, which is one reason thymosin alpha 1 has far more human data behind it.
| Product | Composition | Typical Studied Dose | US Status |
|---|---|---|---|
| Zadaxin (thymosin alpha 1) | Synthetic 28-amino-acid peptide | 1.6 mg subcutaneously, twice weekly | Not FDA-approved |
| Thymalin | Bovine thymus extract, peptide mixture | 10 mg intramuscularly, short courses | Not FDA-approved; sold as a supplement |
| Thymosin beta-4 | Synthetic 43-amino-acid peptide | Varies by study | Not FDA-approved |
Reported Thymosin Alpha 1 Benefits and What the Evidence Shows
Most of the evidence behind thymosin alpha 1 benefits comes from small trials, often run in a single country and rarely replicated at a large scale. The signal is interesting, but it is not definitive.
- Chronic hepatitis B: some trials show better viral clearance when the peptide is combined with antiviral drugs, though response rates vary widely.
- Vaccine response: older adults and dialysis patients given the peptide with influenza vaccine produced stronger antibody responses in several small studies.
- Sepsis and immune suppression: early data suggest faster immune recovery, but mortality benefits have not been reproduced consistently.
- Cancer care: it has been tested alongside chemotherapy and radiation with mixed results.
Two points deserve to be stated plainly. Thymosin alpha 1 is not a proven cure for any disease. Claims that it prevents infections or treats cancer outside a supervised clinical setting are not supported by strong evidence.
Forms, Dosing, and Thymosin Alpha 1 Reconstitution
Where Zadaxin is approved, the typical adult dose is 1.6 mg subcutaneously, often twice weekly for hepatitis B and once daily during a short vaccine-adjuvant course. Dosing always depends on the condition and the prescriber.
Thymosin alpha 1 reconstitution is simple but unforgiving. The vial holds a freeze-dried powder that must be dissolved in the diluent supplied with it, swirled gently, and never shaken. Mixed solution should be refrigerated and used within the window printed on the label.
| Form | How It Is Used | What to Know |
|---|---|---|
| Zadaxin 1.6 mg vial | Subcutaneous injection after reconstitution | Pharmacy-grade in countries where it is approved |
| Research-grade powder | Laboratory use only | Purity and sterility are not guaranteed |
| Nasal spray | Sprayed into the nostrils | Very limited human absorption data |
| Oral capsules | Swallowed | Poor oral bioavailability reported |
Not everyone wants an injection, and that is why thymosin alpha 1 nasal spray has become a popular alternative in the gray-market peptide world. Nasal delivery avoids needles, but human absorption data are thin, and the actual dose delivered is hard to verify.
Side Effects and Safety Considerations
Reported side effects are usually mild and short-lived in published trials. The most common complaints are injection-site soreness, fatigue, low-grade fever, muscle aches, and occasional nausea.
Some groups need extra caution. People with autoimmune conditions, organ transplants, or who are pregnant or breastfeeding should not use thymosin alpha 1 without direct medical supervision, because the peptide changes immune signaling.
Product quality is a separate risk. Research-grade vials sold online are not required to meet pharmaceutical sterility or purity standards, and mislabeled or underdosed product is common. Thymosin alpha 1 is not FDA-approved for human use in the United States, so no US pharmacy can legally dispense it as a treatment. Anyone considering it should speak with a licensed healthcare professional first.
Frequently Asked Questions
Is Zadaxin available in the United States?
No. Thymosin alpha 1 is not FDA-approved for any human use in the United States, so Zadaxin cannot be prescribed or dispensed by US pharmacies. It is approved as a prescription medicine in some other countries, including Italy and China. US suppliers typically sell it as a research chemical that is not intended for human use.
What is the difference between Zadaxin and thymosin alpha 1?
They are the same peptide. Thymosin alpha 1, also called thymalfasin, is the generic name of the active molecule, and Zadaxin is the trade name used by manufacturer SciClone Pharmaceuticals. Studies that describe Zadaxin are describing thymosin alpha 1.
How is Zadaxin typically dosed?
In countries where it is approved, the standard adult dose is 1.6 mg given subcutaneously, usually twice weekly for chronic hepatitis B. Vaccine-adjuvant protocols and other uses follow different schedules. Dosing should always be set by a licensed prescriber.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.